Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine| Pfizer Inc. (NYSE: PFE) | Delayed: 25.06 -0.15 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.19 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 9,031,532 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.06 -0.15 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.19 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 9,031,532 | |||||

